A New Way Forward for Postpartum Depression: Canopie + Reunion

Canopie was founded with a clear mission: to ensure that every expecting and new parent has access to evidence-based mental health care, regardless of where they live, the resources available to them, or the barriers they face.

Of the moms that come into our program:

• 23.1% of Canopie moms come in with low mood
• 40.5% of all Canopie moms want more support

Over the years, we’ve grown alongside the families we support, and above all, we’ve listened. We’ve heard how isolating postpartum depression (PPD) can be and how challenging it is for moms to find the right help. While our core program—a personalized care plan with asynchronous CBT sessions, psychoeducational group classes, and routine health screenings—fully supports so many, we understand that PPD can be complex and persistent, sometimes requiring multiple forms of care.

In line with our mission, we’re excited to share our partnership with Reunion Neuroscience and their RECONNECT Phase II Study, a clinical trial exploring a novel approach to treating postpartum depression. The study is designed to help moms "reconnect"—with their baby(ies), with their relationships, and, most importantly, with themselves.

"We are excited to partner with Canopie to build awareness of the RECONNECT study and support mothers with postpartum depression. This partnership reflects our commitment to improving access to care and support for maternal mental health." -Our partners at Reunion Neuroscience

We’re not alone in our excitement for the potential of this work! Canopie is proud to join leading organizations like the Policy Center for Maternal Mental Health and the Maternal Mental Health Leadership Alliance in supporting this important study.

The investigational treatment at the heart of this study, RE104, is a short-duration psychedelic similar to psilocybin, but designed to create a milder, more time-limited experience. Research into psychedelics as a potential treatment for depressive symptoms has been growing for years, and it’s heartening to see this innovation being explored specifically for postpartum depression—a condition that remains vastly under-treated and under-researched.

If you or someone you know could benefit from this treatment, learn more about the study here.